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Dear Dr Duijts, 
 
Thank you for getting us feedback on the second revised version of our manuscript. Below you will 
find our detailed responses. 
 
 
Major points. 
1. I still believe that the manuscript can be shortened (a lot) to improve readability.  
 
We have shortened it further by thoroughly editing the manuscript. The manuscript is within the 
limits of the journal guidelines (under 8000 words). It’s currently 5995 words excluding Abstract 
and References and 7117 including Abstract and References. 
 
2. Also, please check the English language carefully. A lot of errors have been made.  
 
We have checked our manuscript again carefully and corrected any potential mistakes.  
 
3. Finally, reviewers expressed their concerns (in their comments to the editor) about the 
novelty of this paper, the surplus value, and also about the fact that the results only come 
from interactions with one clinician with a special interest in the area. Major changes have 
to be made before publication is possible. Please be aware that making the requested 
changes will NOT guarantee acceptance. 
 
We are surprised by these expressions of concerns at this stage of the revision process. If the 
reviewers feel we have not addressed their concerns (however, two reviewers have already 
expressed that their concerns were satisfactorily addressed and commended us on our 
perseverance), they should have addressed it directly and explicitly to us. We are also not clear 
what is meant by ‘surplus value’ in this context. We have repeatedly made it clear the limitation 
of having one clinician in our study and therefore we are not sure how else we can express this. 
We strongly believe in the novelty of our findings. No research study is without its limitations 
and we have amply and repeatedly acknowledged ours.  
 
 
Minor points. 
Abstract 
4. Page 5, line 17: shouldn't examining the survivors' experience of this interaction be 'how 
survivors experience this interaction'? In line with the rest of this sentence? 
 
We have made this suggested change. 
 
5. Page 5, line 36: include the before consultant.  
 
We have added ‘the’ before consultant. 
 
Introduction 
6. Page 6, line 20: the growing numbers requires.... is this correct? Shouldn't it be the growing 
numbers require or the growing number requires  
 
We have changed it to ‘growing number’. 
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7. Page 8, line 20: change 'death-related thoughts,' into 'death-related thoughts',  
 
We have made this suggested change. 
 
8. Page 8, line 34: remove the first the  
 
We have made the suggested change. 
 
9. Page 9, line 20: regarding examining, see corresponding remark in the abstract  
 
We have changed it to ‘examining how the survivors experience of this interaction’. 
 
10. Page 9, line 31: change Consultant into consultant 
 
We have made this suggested change. 
 
Methods 
11. Page 9, line 50 and further: this is not exactly what I meant. These patient characteristics 
should be described in the first part of the results section. I meant a participants or, even 
better, a 'study population' paragraph should be included at the beginnings of your methods 
section, with for example where patients were recruited, what the in- and exclusion criteria 
were, and so on. Subsequently, in the results section, specific data / numbers can be 
described. 
 
We have made this suggested change. 
 
12. Also, please check the English language of this paragraph (and throughout the manuscript). I 
would prefer 'the recruited participants'  instread of 'the participants recruited', and 36.4% 
was diagnosed (instead of were). 
 
We have made these suggested changes. 
 
13. Page 11, line 36: change the team were into the team was  
 
We have made this suggested change. 
 
 
Discussion 
14. If you want to combine main findings and interpretation of findings, please name this 
section 'Interpretation of main findings'. 
 
We have made this suggested change. 
 
15. Page 22, line 26-43: this whole part can be deleted because it is just a repetition of what is 
already known.  
 
We have made this suggested change. 
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16. Page 25, line 55. what a consultant needed manage??? needed to manage?  
 
We have made this suggested change. 
 
17. Page 26, line 15. This last finding is a bit strange in this context. It seems that this paragraph 
has not been rewritten as a stand alone 'Implications for research and practice'  paragraph, 
but that only some copy paste actions have been performed. It would advise to be more to 
the point in the implications for research and for practice. Also, hardly any implications for 
research are present. And, this paragraph is really long. I would advise shorten it (a lot), the 
same goes for the conclusion. 
 
We think that the Associate Editor is referring to ‘This last finding points to the importance of raising 
these fears by the health care professional during follow-up’ when she says ‘this last finding is a bit 
strange in this context’. We are not sure why the Associate Editor finds this finding strange and what 
‘context’ she is referring to. We believe that our finding is not strange at all and therefore we have 
not made any changes. 
 
With regard to length of the paragraph and also the conclusion section, we made our best to cut it 
further down. However, you have also asked us to expand on the research implications and 
therefore we have added the following ‘brief’ section in the interests of not making it any longer as 
we have been also criticised for the length of our manuscript: 
 
“In terms of research, our study was limited to one clinical setting and to one clinician with a special 
interest in FCR which is a limitation of our study. Future work needs to confirm our findings in other 
settings and with multiple clinicians. In addition, future work needs to examine whether these fears 
can be raised during consultation without the use of a tool such as PCI.” 
 
Reviewer(s)' Comments to Author: 
Reviewer: 1 
 
Comments to the Author 
1. There is a small error on page 24 line 13: “are” should be “were” so that it reads “which may 
have increased the likelihood that patients’ concerns were discussed.” 
 
We have made this suggested change. 
 
Reviewer: 2 
 
Comments to the Author 
1. The authors should be commended for their persistence. They seem to have addressed all 
the comments adequately. 
 
We thank the reviewer for their acknowledgement of our efforts. 
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Abstract 
Fear of cancer recurrence (FCR) is common among individuals treated for cancer. 
Explorations of how this fear is expressed within an oncology setting and responded 
to are currently lacking. The aim was to investigate how head and neck cancer 
survivors in follow-up consultations express FCR, how a health care professional 
addresses recurrence fears, and examining how survivors experience this 
interaction. We recorded the follow-up consultations of those participants who have 
reported FCR as a concern on the Patient Concerns Inventory. We also conducted a 
follow-up phone interview with the participants. We analysed the transcripts using 
thematic analysis. Five men and six women were recruited, aged 55-87 (mean age = 
64). Follow-up consultation analyses revealed that the consultant used ‘normalising 
FCR,’ ‘reassurance,’ and ‘offer of referral to a counsellor’. Interviews revealed 
themes around how they coped with FCR, relevance of personal history on FCR, and 
the impact of feeling gratitude towards the consultant on expression of FCR. 
Analyses indicate that patients may feel reluctant to raise their FCR with their 
clinician for fear of appearing ‘ungrateful’ or of damaging a relationship that is held 
in high esteem.  Findings indicate the initiation of FCR with patients can be beneficial 
for patient support. 
Keywords: fear of cancer recurrence; consultations; head and neck cancer; 
communication; emotional regulation 
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Introduction 
 End of cancer treatment and attempting to return to normal life can bring 
many challenges for cancer survivors.  Survivors often have to cope with numerous 
ongoing concerns such as lingering side effects and late treatment sequelae (Stein et 
al., 2008), changing work and social roles (Zebrack, 2000), return to work issues 
(Taskila and Lindbohm, 2007), and communication difficulties within the family 
(Northouse et al., 2000).  The growing number of cancer survivors requires those 
health care professionals assisting various aspects of the care of the survivors to be 
familiar with, and open to, discussing issues of concern to patients and their families.  
 A recent comprehensive review showed that adult survivors of many cancer 
types commonly report fears about cancer returning (Simard et al., 2013).  The 
review found that fear of cancer recurrence (FCR) defined recently by an expert 
panel as ‘fear, worry, or concern about cancer returning or progressing’ (Lebel et al., 
2016) was ‘frequently identified as the major concern or one of the top five greatest 
concerns’ (p. 303). Moreover, these fears do not reduce with time, with 18 of the 22 
longitudinal studies showing no change over the periods assessed (which ranged 
from 3 months to 6 years). They are also strongly related to lower global quality of 
life or wellbeing and increased ‘unmet needs’. 
Patient experience of physical symptoms following the completion of 
treatment can be particularly difficult, with physical symptoms often related to 
increased FCR (Simard et al., 2013).  In addition, qualitative evidence shows that 
survivors find the upcoming medical appointments with the healthcare team 
particularly distressing which triggers FCR (Mutsaers et al., 2016).  The cancer 
survivor, contrary to initial conjecture, may not find a check-up (e.g., ultrasound) as 
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reassuring as the health professional expects (Thewes et al., 2012).  Hence, the 
patient’s FCR may increase (Lee-Jones et al., 1997).  Follow-up appointments often 
involve a physical exam or some form of screening (e.g., mammography, palpation 
for neck nodes) which are met with trepidation over what the tests may reveal, and 
the anticipation of relief when the results do not indicate recurrence (McGinty et al., 
2016).  As Arora (Arora, 2003) shows in a review of the literature, the health care 
professionals’ communication behaviour (e.g., offer of choice of treatment) with 
survivors is an important influence on outcomes such as patient satisfaction, 
adherence, anxiety, and psychological distress. Hence, clinical services are obligated 
to ensure good communication within the clinic setting when interacting with 
patients so that clinicians have the opportunity to identify and manage these fears.  
Another recent systematic review highlighted FCR as a key unmet need for 
haematological cancer patients (Swash et al., 2014), thus highlighting the need to 
investigate beyond the common cancers and explore FCR levels and predictors in 
other patient groups.   
In a recent study by Custers et al., (Custers et al., 2017), mediational analyses 
showed that internal cues such as feeling sick and bodily sensations as well as 
external cues such as cancer-related media news and contact with health 
professionals increased FCR which in turn resulted in limited planning for future and 
body checking.  Qualitative investigation of these fears show that intrusive thoughts, 
distress, and impact on functioning are common features of FCR as well as features 
such as ‘death-related thoughts’, and ‘belief that the cancer will return’ (Mutsaers et 
al., 2016). To our knowledge, no qualitative study examined how the expression of 
FCR took place in an oncology setting and how this was addressed. 
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Communication between patients and health professionals in offering 
improved cancer care is crucial. In the domain of fear of progression which is a 
concept often used interchangeably with FCR, there is some evidence showing that 
the way in which the medical encounter takes place and information offered can 
have an impact on these fears (Gross et al., 2015). In Gross et al’s study (Gross et al., 
2015), interruptions during the initial medical encounter caused a lower decrease in 
fear of progression from the initial encounter to the 3-day follow-up. In addition, 
those patients who found the information provided comprehensible at the initial 
encounter, had subsequently reduced fear of progression.  
The aim of this study was to investigate how head and neck cancer survivors 
express FCR in follow-up consultations, how a health care professional addresses 
recurrence fears, and examining how the survivors experience of this interaction in a 
follow-up interview. Specifically, we aimed to answer the following questions: 
1. Is the FCR issue expressed in the consultation? And if so, who elicits the 
presentation of this fear? 
2. How does the consultant manage the patient’s FCR, should it arise in the 
consultation? 
3. What factors might be responsible for some patients to focus intensely on 
FCR? How do they self-manage this fear and any triggers for it? 
4. How do survivors respond to the discussion around FCR?  Specifically, did the 
discussion ease their concerns and abate their anxiety? 
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Method 
All recruited participants were patients of one clinician (SR) attending his outpatient 
review clinic following primary cancer treatment in a consecutive manner.  Patients 
were required to be over the age of 18, currently disease free, and to have 
completed treatment at least three months previously (Mean = 38.1 months, SD = 
38.4 months). 
Procedure 
This study received ethical approval from both the National Research Ethics Service 
and local research governance at participating sites.  Patients who visit the follow-up 
clinic are routinely invited to complete the Patient Concerns Inventory (PCI; (Rogers 
et al., 2009)) before their outpatient clinic appointment as a feature of standard 
care. The PCI is a measure developed from clinical case material that highlighted the 
phenomena of patients feeling reluctant to discuss psychosocial concerns, such as 
FCR, with their health care professionals (Humphris and Ozakinci, 2006) and was 
developed as a tool to detect patient concerns in people with head and neck cancer 
(Rogers et al., 2009).  It consists of 57 items that patients are invited to select if 
applicable to help guide their consultation.  Sample items include appetite and 
fatigue/tiredness along with FCR, and is presented in either a pencil and paper 
format or computer touch screen. 
For the recruitment period, we checked individual PCI responses after each 
patient completion and identified those patients who selected ‘fears of cancer 
recurrence’ as a concern to discuss with their clinician.  These patients were then 
approached by the researcher (BS) prior to their consultation to consider 
volunteering as a study participant.  On consent, the patient’s consultation was 
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audio-recorded and a follow-up interview, either via telephone or in person, was 
arranged.  Follow-up interviews were conducted within 48 hours of outpatient 
appointment and followed a semi-structured format.  The interview focused on the 
following broad topics: 
• Presence of patient ongoing concerns; 
• The impact of these concerns on everyday life; 
• The frequency of FCR and intensity of cancer recurrence related thoughts; 
• Whether the patient believed that their clinical team was aware of their FCR 
and recurrence related thoughts; 
• Whether the consultation had explicitly focused on their FCR and whether 
this focus had been helpful in alleviating fears; 
• Whether any continuing support been offered 
  
Data Analysis 
 Questions 1 and 2 were addressed by an analysis of consultation recordings, 
whereas questions 3 and 4 were mainly addressed through analyses of follow-up 
interview data. Audio-recordings of both the consultations and interviews were 
transcribed verbatim.  All data were analysed using a thematic analysis approach 
(Braun and Clarke, 2006) with a further content analysis employed within the 
transcripts of the consultations.  Thematic analysis is a qualitative approach that has 
often been utilised within psycho-oncology research (e.g., (Nilsson et al., 2013, 
Denford et al., 2011)) and involves the identification of themes that emerge as 
important for the description of the phenomenon in question (Daly et al., 1997).  In 
order for themes to be identified, a process of reading, note taking, then re-reading 
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the data in order to begin to recognise patterns within the data must take place 
(Rice and Ezzy, 1999).  Emergent themes, then, become the basis of the analysis.   
All transcripts were analysed in depth by two researchers independent of 
each other (BS and GO). The resulting framework was discussed at length and a 
consensus agreed.  Validation was achieved through extensive discussion with a 
third team member (NHW). 
In quotes below, the first number denotes the participant number followed 
by gender (F/M), age of the participant, and whether it is the consultation (C) or the 
follow-up interview (I). 
Results 
Study Population 
 In total, five males and six females were recruited.  All were aged between 55 
and 87 (mean age = 64).  All participants had been diagnosed and actively treated for 
head and neck cancer.  Primary tumour sites were most commonly oral cavity and 
pharyngeal.  36.4% of the sample was diagnosed with low disease severity (Stages 1 
and 2), with 63.6% of the sample being diagnosed with high disease severity (Stages 
3 and 4).  All had completed treatment and were currently disease free at the time 
of study recruitment.  The most common treatments were combined surgery and 
radiotherapy (55%), followed by chemoradiotherapy (27%).  We had audio 
recordings from all consultations but one and interview recordings from all 
interviews but one (due to technical difficulties, two recordings were not available). 
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Analysis of Consultation Recordings 
 In all consultations but one, it was the consultant who brought up the issue 
of FCR, presumably prompted by their access to the PCI responses. In eight of the 
cases, referral for emotional support was made. On one occasion, the participant 
was already seeing a counsellor. On two occasions, the participant accepted the 
offer of referral. On other occasions, the participants did not want any referral, citing 
other sources of support (e.g., carer) or downplaying the extent of the impact of the 
fears on them.  Bringing up the FCR usually happened following a general, broad 
opening, which was followed by a discussion around physical symptoms experienced 
by the patient. The consultant, then, preceded to enquire about the frequency of 
these fears as well as what triggers them. In most cases, the consultant used several 
strategies to help patients cope with their FCR. 
Consultant: “I noticed on the, on the computer system you mentioned about 
the worry about the cancer coming back, how often do you notice that, what’s…? 
(3M62C) 
3M62C: Every day. 
Consultant: Every day, what makes you notice that? 
3M62C: Sorry…? 
Consultant: What makes you notice it? 
3M62C: Erm mostly when I open my mouth and I feel things, you know, 
erm…it’s something that doesn’t go away.” 
NORMALISING THE FEAR 
 The consultant normalised the fears as something that can be expected after 
such a diagnosis and treatment. 
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‘..Well, it’s understandable, it’s a healthy thing to be’ (4F60C) 
‘… I mean it’s a natural concern, isn’t it? You’ve had cancer, you look like 
you’re cured, that’s what we expect, water’s passing under the bridge now. Erm that 
and that’s fantastic but there can still be that niggle, can’t there?’ (3M62C) 
REASSURANCE  
The consultant reassured patients by various means.  First, he used 
information about the duration since diagnosis and treatment as providing 
reassurance. 
‘.. but 3 years has gone by and if there was going to be a problem, near 
enough invariably, as sure as eggs are eggs by now, we’d have found it’.  (2M55C) 
‘So the chance of it coming back now is really, really, really, really, very very 
very small’ (2M55C) 
 The consultant also reassured by indicating how head and neck cancer 
compares favourably with other cancer sites with regard to recurrence.  Frequently, 
this comparison was made with breast cancer. 
‘Because, you know, in many ways, you know, if you were gonna run into 
trouble, we’d have, we’d have had it by now. Now I’m looking at a patient who’s 
cured. It’s not like prostate cancer that can come back or breast cancer that can 
come back years and years down the line, that’s not normally the way it is. If it’s 
going to be a problem, we know within a year, 18 months’. (3M62C) 
The consultant almost always conducted a physical exam and used that as an 
opportunity to reassure patient with regard to any symptoms.  Despite using 
techniques to reassure, the consultant expressed the need for vigilance and caution.  
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‘We just need to be very vigilant’ (6M70C) 
 Furthermore, the consultant offered a discussion around when the next 
follow-up should be. This revolved around how the frequency of follow-up 
appointments would potentially impact FCR. The consultant often emphasised that 
the patient could always call him if there was any concern with regard to fears about 
cancer coming back (e.g., triggered from a symptom experience). 
“.. So, let’s go for six months and I’ll get… and I can always, you can, you can always 
bring it forward by phone… (3M62C)” 
OFFERING THE POSSIBILITY OF REFERRING TO A COUNSELLOR 
 The consultant often offered this service facility and on two occasions, this 
was accepted. 
“I still feel that probably getting somebody who’s experienced with looking 
after patients with this would be helpful to you. “ (5F63C)  
“Actually I really believe it would be…it’s got the possibility to ease my mind” 
(5F63C) 
Analysis of Patient Interviews 
 The analysis of the participants’ interviews revealed a range of themes 
relating to patients’ FCR and key barriers for these fears to be expressed and 
managed. 
 
TRIGGERS OF FCR 
 Participants identified a series of triggers for their fears, some of which were 
directly related to sensations within their bodies while others were related to 
external events. 
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 When patients noticed potential symptoms of a recurrence, this immediately 
created concerns.  If an area of the body that had been previously affected by 
cancer, generally the throat or the mouth, became sore or changes of any kind were 
observed, then this was experienced as a strong trigger for FCR. 
“I did have a concern, um a few months back where I found some swollen glands in 
me neck” (2M55I) 
 While symptoms that were directly related to the previous cancer were 
related to FCR, so were somatic concerns more generally.  Some participants 
associated any changes or pains within their bodies as being potential indicators of a 
recurrence, regardless of how common or unrelated the perceived symptom might 
be.  
 “It might be a little pain to everybody else but I’m aware” (7M55I) 
 The presence of external reminders of cancer, notably charity advertisements 
on the television or radio, meant that participants were no longer able to distract 
themselves actively to forget about their previous illness or to concentrate on other 
things as many described trying to do. 
“There’s a lot on TV today… It just, you’ve forgotten about it and then, suddenly it 
registers again” (4F60I) 
 Follow-up appointments were either seen in a strongly positive manner or 
were deemed something to be feared.  In either case, knowing that they were going 
to see their clinician imminently meant that participants were unable to avoid their 
fears and the possibility that they would soon be given the bad news that their 
cancer had returned.   
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“I am terrified for coming seeing you, I’m actually sitting here terrified to walk 
through that door” (3M62I) 
COPING WITH FCR 
 A commonly reported method of coping with FCR was distraction.  A variety 
of methods were employed, all with the fundamental aim of providing the mind with 
something more positive to focus on than the possibility of a cancer recurrence. 
“I invested in my letter, which I’m writing, or painting, it fills the habit” (7M55I) 
 Some participants felt that their ability to cope, or not, with their diagnosis 
was in part due to thei  personality. Some participants believed that their underlying 
personality meant that they were more able to keep positive despite their fears, 
while others identified their FCR as being inevitable given their natural propensity to 
worry.   
“I think I’ve got a positive attitude anyway” (6M70I) 
 Having a confidante was often perceived to be a vital aspect of being able to 
cope with, or manage, fears. 
“If you’re on your own and you go home, and you sit there all on your own, no one to 
talk to… that is a different thing to me, I have someone to talk to” (10F74I) 
RELEVANCE OF PERSONAL HISTORY 
 A person’s background and the prior knowledge and experiences that they 
brought to their cancer experience was felt to strongly impact upon how cancer was 
perceived by the individual.  Having a family history of cancer, particularly, where a 
family member had passed away as a result of the disease, was believed to 
compound any fears about the cancer returning. 
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“watching, erm, me Dad getting eaten away by cancer.  And seeing the way he went 
and having the fear of if… am I gonna go down that road?” (4F60I) 
The person’s own previous experiences of cancer also fed into how strongly 
the prospect of a recurrence was perceived to be a real fear.  In cases where 
treatment was experienced as traumatic or, in the case of one participant, they had 
an on-going co-morbid diagnosis, the fear that the cancer may return was keenly 
felt. 
“the tracheotomy is the worst thing you could have” (10F74I) 
For one participant in particular, the presence of past difficulties (alcohol 
dependency) created a negative comparison regarding the amount of support 
available for concerns relating to their cancer.  The participant felt that the amount 
of support available to them as a cancer patient was less than is available for other 
conditions he had.  The consequence was a concern that they would be inadequately 
supported, should their cancer return. 
“Because I suffer with alcoholism, the amount of help I receive through that is 
enormous compared to [this]” (7M55I) 
THE CAUSES OF PARTICIPANTS’ FEARS 
 Some specific triggers and correlates to the presence of FCR have been 
highlighted. Having to cope again with the shock of a diagnosis and the difficulties of 
treatment should the cancer return was identified as a concern. Participants felt 
unsure as to whether they were physically and emotionally strong enough to repeat 
their previous experience of cancer. 
“I feel as though… I don’t know what I’d do if it reappeared” (8F50I) 
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Many expressed the worry that if the cancer returned, it would be 
untreatable and that the diagnosis would be terminal. 
“the worst thing you can have said you is that, if it comes back there’s nothing we 
can do about it” (10F74I) 
Likewise, even when intervention was considered likely, the need to repeat 
treatment that has been traumatic or to potentially need to undergo further 
treatment that could be disfiguring or disabling in some way was stated as 
promoting fear. 
“Seeing people with half a face… if I had any more removed from my mouth I’d end 
up like my friend who’s had her jaw out” (10F74I) 
 The impact that a recurrence might have on the participant’s family members 
was a common concern.  This aspect of FCR was raised particularly in cases where 
the participant acted as a carer for a family member or had children. 
“I got the people that I’m very worried about, when I started me daughter was only 
18… and I look after me Mum who’s 98 in January” (5F63I) 
 For some, it was the specific impact of cancer that created their fear.  When a 
participant believed that the cancer would have a significant negative effect on their 
physical health causing certain death, this triggered FCR, regardless of whether this 
belief was centred in a realistic assessment of the physical impact of recurrence. 
“I believe I’m either going to choke to death or starve to death, one of the two” 
(2M55I) 
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GRATITUDE TO HEALTH CARE PROFESSIONALS AND THE IMPACT ON EXPRESSION OF 
FEARS 
 Many participants described feeling uncomfortable, in some way, in raising 
FCR with their clinicians, and, if not for the PCI, felt that this was not something that 
they would be able to raise independently.  The central reason for this appears to be 
due to of a sense of gratitude to their clinicians and a sense of causing them offence 
by suggesting that the treatment received may not have been fully successful.  
Deference to their clinician’s expert knowledge and understanding of their illness 
meant that participants were unwilling to raise any concerns that could be perceived 
as challenging this authority. 
“You don’t like to argue with what he says do you? He’s the expert.” (6M70I) 
 In addition, participants were fearful of impacting negatively upon a highly 
valued relationship. 
“I hope I haven’t made [Dr] feel, erm, ‘obviously she feels I haven’t done a good job’, 
erm, cos that couldn’t be further from the truth, cos I’ve got so much faith” (8F50  
 There was a belief that raising any concerns that might imply that clinicians 
had not done a good job or had missed something could create offence which was 
something to be actively avoided. 
“you want to please the people who give you this chance” (7M55I) 
 Similarly, participants did not want to be seen to be complaining by people 
who they held in such high esteem. 
“I don’t want to appear ungrateful, I don’t know what’s the matter with me” (9F76I) 
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Accordingly, participants were reluctant to raise FCR without prompting.    
“if that hadn’t been brought up and that hadn’t have been spoken about, I’d have 
come out of there in the same way, as I went in there” (5F63I) 
In addition, participants expressed that they did not expect emotional 
support from their consultant over and above what they already provide: 
2M55I: Er, the specialist cancer health, erm, has been provided by [PROF1] team and 
he’s got a damn sight more important things on his hands such as other people to 
cure who are suffering from cancer, er, than to be holding my hand all the time or, 
to, keep trying to work, work me head better, and so I’ll go to me GP [Cough] sorry, 
I’ll go to me GP over that. 
 
Interviewer: “And, would, is it just do you think oh they’re too busy or do you not 
really feel comfortable talking about that sort of thing with the clinical team?” 
5F63I: “I think, I think I suppose it’s a bit of both, I think they’re too busy, think 
they’ve got enough to do I mean they’re got a lot of people in the same boat and 
y’know they’ve got a lot of dealing with more, the actual physical things with you, so 
I don’t think, I just don’t think to go in and put, I don’t see what they can do about it I 
suppose, so you go in, sort the problem out, or say your fine or whatever happens to 
be, get on with that and I wouldn’t dream of bothering them. But I don’t say I 
wouldn’t be comfortable because as I say when I spoke to Doctor about it, this time, 
honestly I walked out the other day when we were there and I got into my car and I 
felt fantastic.”  
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Discussion 
Interpretation of main findings 
 In our study, we observed that in almost all of the consultations, the 
consultant brought up the issue of FCR and led the discussion. The use of PCI, 
appeared to facilitate the identification and elaboration of psychosocial issues, in 
particular, FCR which may have gone undetected otherwise.  It is possible that 
without the prompting that this consultant gave in the initial stages of the 
consultation that FCR concerns would have still been expressed by the patient later 
in the consultation.  It is possible that the use of the PCI itself may provide the 
patient with a sufficient sense of ‘permission’ to raise this concern.  A recent report 
in the same specialist clinical service (with different clinicians) tends to support this 
suggestion with a greater likelihood of clinicians responding with providing 
opportunity for patients to discuss their emotional cue or concern expression with 
increased duration of the consultation (Zhou et al., 2014). However, we should 
recognize that it is possible that the patients might have still broached their concern 
regarding recurrence without the use of PCI. 
 We observed that several methods were employed in the consultation to 
deal with FCR. For instance, the consultant validated this fear for the patient by 
normalising its presence. However, the use of an emotional validation of this fear 
was not taking place in isolation. The consultant also conducted a physical 
examination, which provided further highly relevant and personalised health 
information. The close physical intimacy and delicate examination used by the 
clinician (neck palpation) to detect potentially swollen lymph nodes, for example, 
reinforces the clinical relationship with the patient and consultant’s credibility to 
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give statements on health status and recommendations. It was also apparent that 
there was due caution in what the physical examination indicated, wherever 
necessary. 
 Other methods for elaborating on the patient’s health status was to 
contextualise the results of the examination, wound healing, and general progress 
for the patient.  This included highlighting aspects of the participant’s disease in 
relation to time since diagnosis and how it compares to other types of cancer. These 
‘factual’ elements of cancer were raised to ‘reassure’ the patient by concentrating 
on the positive indications. It appeared that the consultant was actively attempting 
to assist with the creation of a mental model of the cancer the participant had and 
link this model to the emotional experience of the cancer and recurrence threat 
(Leventhal et al., 2004). The consultation also involved discussion of how to assist 
with the coping of these fears and included negotiating when the next follow-up 
appointment would take place and offering emotional counselling referral.  In many 
cases, bringing up the possibility of referral to emotional support was welcome and 
taken up on two of the cases.  
 Following the consultations, we interviewed the participants with regard to 
their experience and management of these fears and the extent to which the 
consultations assisted them. We found that participants mentioned several triggers 
of this fear, including encountering representations of cancer in media that they felt 
they had little control over as well as experiencing physical symptoms. Particularly, 
the role of physical symptoms as a strong determinant of fears about cancer 
returning was one of the major findings of a recent systematic review (Simard et al., 
2013) and an early theoretical formulation of FCR (Lee-Jones et al., 1997). Previous 
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experience of cancer, especially, witnessing the death of a parent was also related to 
the experience of these fears. A recent paper has formally constructed the 
mechanism of how an individual may have increased health anxiety due to exposure 
of parental illness (Alberts and Hadjistavropoulos, 2014). Participants also perceived 
the possibility of recurrence particularly threatening, implying a death sentence the 
second time round. Participants mentioned using distraction as a way of coping with 
fears of cancer coming back.  
The personality feature of having a positive attitude was also perceived as 
helping with how one deals with this fear. It is known from an extensive literature 
review that optimism is associated with more problem-focused coping (Nes and 
Segerstrom, 2006). The added value of being of an optimistic personality is that the 
individual can adjust their coping approach according to the limits of being able to 
chance the ‘stressor’, in this case the possibility of a cancer recurrence. These views 
expressed about remaining positive are a reflection of the Mental Adjustment to 
Cancer scale. A recent report of a Korean short version of this measure confirmed 
that fatalism and fighting spirit could be encapsulated into a factor more widely 
accepted as ‘positive attitudes’ (Kang et al., 2008).  The corollary construct of having 
a negative attitude was to be avoided, as relayed by participants.  This ‘negative 
affectivity’ is an over-riding personality dimension that is likely to be implicated in 
the development of FCR, although it has yet to be studied longitudinally to enable 
formal testing.   
Implications for research and practice 
 Although we observed that the participants were willing to talk about their 
fears during follow-up once it was raised, there was also concern about what these 
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expressions of one’s concerns would imply for their relationship with their care 
provider. Participants often expressed gratitude for the care the consultant has 
provided and expressed concern that the discussion of recurrence fears may indicate 
to the consultant that the participant questioned their authority and expertise. In 
addition, dealing with psychosocial issues was not perceived to be in the domain of 
what a consultant needed to manage.  A survey of oncology staff (n = 141) in 
Australia has shown that they are aware that more than 50% of their patients suffer 
FCR (Thewes et al., 2014) .  Only one in five (21%) reported that they referred on 
their patients with high FCR, illustrating that there are barriers to gaining 
professional support for these patients.  The positive finding from the survey was 
that the vast majority (99%) were interested to receive training in assisting patients 
with high FCR levels. 
 It may be worthwhile for health care professionals to be aware of the feelings 
of gratitude for the treatment they have provided and how from their patients’ 
perspective these feelings can impede the discussions of these fears.  Clinicians may, 
for example, need to adopt sensitive language to facilitate this communication. We 
need to recognize that reassurance can provide a short-term relief for the anxiety 
which can further reinforce reassurance-seeking behaviour (Salkovskis, 1996). It is 
important that reassurance is provided within the context of restructuring or 
reformulating the content of the worry, in other words, the risk of recurrence.   
 Importantly, within the context of psychosocial care of cancer patients, 
detecting these fears (either through PCI or by simply asking about them) needs to 
be coupled with the provision of further support and therapeutic assistance by 
psycho-oncology services, if required. Patients with moderate to extensive FCR levels 
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need to receive patient-centred support or intervention that is commensurate with 
their clinical presentation (Cruickshank et al., In press). A previous report has 
highlighted this difficulty for cancer treatment services:  There is reticence to invite 
discussion about psychological problems associated with the diagnosis, treatment 
and follow-up care because of lack of training, poor methods of screening and 
minimal provision of referral centres for specialist services (Absolom et al., 2011).  It 
is important to be aware that patients with high levels of distress may in fact receive 
identical support from services such as cancer nurse specialists.  However, what 
appears central is the patient impression of the support received.  This has been 
reported to be deficient in the most distressed patient receiving comparable services 
(Clark et al., 2009). 
 In terms of research, our study was limited to one clinical setting and to one 
clinician with a special interest in FCR which is a limitation of our study. Future work 
needs to confirm our findings in other settings and with multiple clinicians. In 
addition, future work needs to examine whether these fears can be raised during 
consultation without the use of a tool such as PCI. 
Strengths and Limitations 
 This is the first study to our knowledge that has drawn together audio-
recordings of out-patient follow-up consultations and in-depth interviews with the 
patients involved.  The ability to match the experience of the clinic visit and the 
patient’s detailed expression of their concerns felt within the session and how they 
might have been revealed was highly instructive and we believe has identified some 
important interactional and clinical management processes.  Our study, as 
acknowledged above as a limitation, included a single cancer centre and only one 
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consultant who has a special interest in patient-centred care by developing the PCI 
which may have increased the likelihood that patients’ concerns were discussed. In 
that regard, we should be cautious in generalising from these findings.  We do 
recognise that this means that these research questions need to be examined in 
multiple oncology settings with different health care professionals. It is also possible 
that the recording of the session might have impacted the session but we are 
reassured that several participants mentioned that they did not feel the consultation 
was any different (though not systematically assessed). We also were missing one 
consultation and one interview recording. We have not kept track of how many 
participants were approached and therefore do not know how representative these 
participants are of the patients seen at this clinic. Nonetheless, these findings are 
novel and give some important insight for guiding and planning further research and 
clinical interventions. 
Conclusion 
 In conclusion, our findings have implications both for patients and health 
care professionals who are in contact with them. General models of good practice 
and also systems of evaluation of the ways in which enhanced communication can 
facilitate health care are well-acknowledged (Back et al., 2005, Street et al., 2009, 
Fellowes et al., 2004). Our findings indicate that patients may feel reluctant to raise 
their fears about cancer returning with their clinician for fear of appearing 
‘ungrateful’ or of damaging a relationship that is held in high esteem.  In addition, 
patients prioritise the physical aspects of their care and have reduced expectations 
to received emotional support from their clinicians. They are quite aware of the 
pressures on the clinics and staff time. This raises the possibility that FCR is under-
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reported within this patient group.  In the case of this study, patients were 
encouraged to express fears, however, this may reflect the fact that the consultant 
in question had a special interest in FCR which is acknowledged above. Whether this 
communication practice is achievable in other oncology settings needs to be 
addressed. The consultant highlighted FCR as an issue in the consultation if the 
patient had indicated they wanted to discuss this concern using the PCI.  It is likely 
that explicitly raising the issue of FCR with the patient may remove the identified 
barrier to disclosing FCR in the clinic setting providing the possibility of organising 
support for those with high levels of FCR.  
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